CoQ10 and D-ribose in Patients With Diastolic Heart Failure
Reducing Symptom Burden in Patients With Heart Failure With Preserved Ejection Fraction Using Ubiquinol and/or D-ribose
Sponsor: National Institute on Aging (NIA)
Listed as NCT03133793, this PHASE2 trial focuses on Heart Failure, Diastolic and remains completed. Sponsored by National Institute on Aging (NIA), it has been updated 12 times since 2018, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Apr 2022 — Jul 2024 [monthly]
Completed PHASE2
-
May 2021 — Apr 2022 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Apr 2021 — May 2021 [monthly]
Active Not Recruiting PHASE2
▶ Show 7 earlier versions
-
Feb 2021 — Apr 2021 [monthly]
Active Not Recruiting PHASE2
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Feb 2020 — Jan 2021 [monthly]
Recruiting PHASE2
-
May 2019 — Feb 2020 [monthly]
Recruiting PHASE2
-
Jun 2018 — May 2019 [monthly]
Recruiting PHASE2
-
May 2018 — Jun 2018 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Jun 2017 — May 2018 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute on Aging (NIA)
- University of Kansas Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .